Enhancing the precision of auxiliary diagnosis for lung cancer through use of <i>SHOX2</i> and <i>RASSF1A</i> methylation status in lung biopsy and lymph node biopsy specimens.

Transl Lung Cancer Res · 2025 · PMC12000937 · PMID 40248719

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Our results indicated that the sensitivity of SHOX2 methylation was higher in male than in female patients, although this difference did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Enhancing the precision of auxiliary diagnosis for lung cancer through use of &lt;i&gt;SHOX2&lt;/i&gt; and &lt;i&gt;RASSF1A&lt;/i&gt; methylation status in lung biopsy and lymph node biopsy specimens.

The sentences

Enhancing the precision of auxiliary diagnosis for lung cancer through use of <i>SHOX2</i> and <i>RASSF1A</i> methylation status in lung biopsy and lymph node biopsy specimens.